These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9788821)

  • 1. Activation of matrix metalloproteinases in the failing human heart: breaking the tie that binds.
    Mann DL; Spinale FG
    Circulation; 1998 Oct; 98(17):1699-702. PubMed ID: 9788821
    [No Abstract]   [Full Text] [Related]  

  • 2. Matrix metalloproteinases and their inhibitors in the nervous system: the good, the bad and the enigmatic.
    Campbell IL; Pagenstecher A
    Trends Neurosci; 1999 Jul; 22(7):285-7. PubMed ID: 10484748
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiac remodeling and failure From molecules to man (Part II).
    Fedak PW; Verma S; Weisel RD; Li RK
    Cardiovasc Pathol; 2005; 14(2):49-60. PubMed ID: 15780796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The matrix metalloproteinases and their inhibitors.
    Murphy G; Docherty AJ
    Am J Respir Cell Mol Biol; 1992 Aug; 7(2):120-5. PubMed ID: 1497900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of matrix metalloproteinase activity.
    Murphy G; Willenbrock F; Crabbe T; O'Shea M; Ward R; Atkinson S; O'Connell J; Docherty A
    Ann N Y Acad Sci; 1994 Sep; 732():31-41. PubMed ID: 7978800
    [No Abstract]   [Full Text] [Related]  

  • 6. Emerging role of matrix metalloproteinases in the pathophysiology of cardiac diseases.
    Díez J
    Eur J Clin Invest; 2002 May; 32(5):291-4. PubMed ID: 12027866
    [No Abstract]   [Full Text] [Related]  

  • 7. Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells.
    Li YY; McTiernan CF; Feldman AM
    Cardiovasc Res; 1999 Apr; 42(1):162-72. PubMed ID: 10435007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic remodeling of extracellular matrix.
    Birkedal-Hansen H
    Curr Opin Cell Biol; 1995 Oct; 7(5):728-35. PubMed ID: 8573349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling.
    Li YY; McTiernan CF; Feldman AM
    Cardiovasc Res; 2000 May; 46(2):214-24. PubMed ID: 10773225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases in pathophysiology and treatment of heart failure.
    Feldman AM; Li YY; McTiernan CF
    Lancet; 2001 Mar; 357(9257):654-5. PubMed ID: 11247546
    [No Abstract]   [Full Text] [Related]  

  • 11. Tissue inhibitors of matrix metalloproteinases in cancer.
    Blavier L; Henriet P; Imren S; Declerck YA
    Ann N Y Acad Sci; 1999 Jun; 878():108-19. PubMed ID: 10415723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIMPs and cardiac remodeling: 'Embracing the MMP-independent-side of the family'.
    Vanhoutte D; Heymans S
    J Mol Cell Cardiol; 2010 Mar; 48(3):445-53. PubMed ID: 19799912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases: a review.
    Birkedal-Hansen H; Moore WG; Bodden MK; Windsor LJ; Birkedal-Hansen B; DeCarlo A; Engler JA
    Crit Rev Oral Biol Med; 1993; 4(2):197-250. PubMed ID: 8435466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation mechanisms of matrix metalloproteinases.
    Nagase H
    Biol Chem; 1997; 378(3-4):151-60. PubMed ID: 9165065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of matrix metalloproteinases in tumor cells].
    Seiki M
    Gan To Kagaku Ryoho; 1993 Feb; 20(3):387-92. PubMed ID: 8439185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural biochemistry and activation of matrix metalloproteases.
    Kleiner DE; Stetler-Stevenson WG
    Curr Opin Cell Biol; 1993 Oct; 5(5):891-7. PubMed ID: 8240832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases and their inhibitors in tumor progression.
    De Clerck YA; Shimada H; Taylor SM; Langley KE
    Ann N Y Acad Sci; 1994 Sep; 732():222-32. PubMed ID: 7978795
    [No Abstract]   [Full Text] [Related]  

  • 18. Matrix metalloproteinases.
    Nagase H; Woessner JF
    J Biol Chem; 1999 Jul; 274(31):21491-4. PubMed ID: 10419448
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of matrix metalloproteinases during extracellular matrix turnover.
    Corcoran ML; Kleiner DE; Stetler-Stevenson WG
    Adv Exp Med Biol; 1995; 385():151-9; discussion 179-84. PubMed ID: 8571826
    [No Abstract]   [Full Text] [Related]  

  • 20. Advanced glycation endproducts: activators of cardiac remodeling in primary fibroblasts from adult rat hearts.
    Daoud S; Schinzel R; Neumann A; Loske C; Fraccarollo D; Diez C; Simm A
    Mol Med; 2001 Aug; 7(8):543-51. PubMed ID: 11591890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.